5-aminolevulinic acid-incorporated nanoparticles of methoxy poly(ethylene glycol)-chitosan copolymer for photodynamic therapy

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 809-819

  Chung, Chung Wook ^a   Chung, Kyu Don ^b   Jeong, Young Il ^a   Kang, Dae Hwan ^a  

^a Pusan National University Yangsan Hospital   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

5 ALA; Chitosan; Colon cancer; Nanoparticles; Photosensitizer; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; COPOLYMER; METHOXY POLYETHYLENE GLYCOL CHITOSAN COPOLYMER; NANOPARTICLE; PROTOPORPHYRIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL VIABILITY; COLORECTAL CARCINOMA; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG MECHANISM; DRUG RELEASE; IN VITRO STUDY; LIGHT IRRADIANCE; MICROSCOPY; PARTICLE SIZE; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PHYSICAL CHEMISTRY; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR CELL DESTRUCTION;

5-ALA; CHITOSAN; COLON CANCER; NANOPARTICLES; PHOTOSENSITIZER; PROTOPORPHYRIN IX;

AMINOLEVULINIC ACID; CELL LINE, TUMOR; CHITOSAN; COLONIC NEOPLASMS; DRUG CARRIERS; HUMANS; NANOPARTICLES; PARTICLE SIZE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POLYETHYLENE GLYCOLS; PROTOPORPHYRINS;

EID: 84874440746     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S39615     Document Type: Article

References (41)

1. Peng Q, Warloe T, Berg K, et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer. 1997;79:2282-2308.
2. Brunner TB, Eccles CL. Radiotherapy and chemotherapy as therapeutic strategies in extrahepatic biliary duct carcinoma. Strahlenther Onkol. 2010;186:672-680.
3. Morse M, Langer L, Starodub A, Hobeika A, Clay T, Lyerly HK. Current immunotherapeutic strategies in colon cancer. Surg Oncol Clin N Am. 2007;16:873-900.
4. Touchefeu Y, Harrington KJ, Galmiche JP, Vassaux G. Review article: gene therapy, recent developments and future prospects in gastrointestinal oncology. Aliment Pharmacol Ther. 2010;32:953-968.
5. Lee JH, Kang DH, Kim JY, et al. Endoscopic bilateral metal stent placement for advanced hilar cholangiocarcinoma: a pilot study of a newly designed Y stent. Gastrointest Endosc. 2007;66:364-369.
6. Yoo JJ, Kim C, Chung CW, Jeong YI, Kang DH. 5-aminolevulinic acid-incorporated poly(vinyl alcohol) nanofiber-coated metal stent for application in photodynamic therapy. Int J Nanomedicine. 2012;7:1997-2005.
7. Almeida RD, Manadas BJ, Carvalho AP, Duarte CB. Intracellular signaling mechanisms in photodynamic therapy. Biochim Biophys Acta. 2004;1704:59-86.
8. Buytaert E, Dewaele M, Agostinis P. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta. 2007;1776:86-107.
9. Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61:250-281.
10. Zoepf T, Jakobs R, Rosenbaum A, Apel D, Arnold JC, Riemann JF. Photodynamic therapy with 5-aminolevulinic acid is not effective in bile duct cancer. Gastrointest Endosc. 2001;54:763-766.
11. Peng Q, Warloe T, Moan J, et al. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. Cancer Res. 2001;61: 5824-5832.
12. Friesen SA, Hjortland GO, Madsen SJ, et al. 5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors. Int J Oncol. 2002;21:577-582.
13. Peng Q, Berg K, Moan J, Kongshaug M, Nesland JM. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol. 1997;65:235-251.
14. Gaullier JM, Berg K, Peng Q, et al. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res. 1997;57:1481-1486.
15. Casas A, Batlle AM, Butler AR, et al. Comparative effect of ALA derivatives on protoporphyrin IX production in human and rat skin organ cultures. Br J Cancer. 1999;80:1525-1532.
16. Perotti C, Fukuda H, DiVenosa G, MacRobert AJ, Batlle A, Casas A. Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies. Br J Cancer. 2004;90:1660-1665.
17. Hürlimann AF, Hänggi G, Panizzon RG. Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion. Dermatology. 1998;197:248-254.
18. Morrow DI, McCarron PA, Woolfson AD, et al. Novel patch-based systems for the localised delivery of ALA-esters. J Photochem Photobiol B. 2010;101:59-69.
19. Casas A, Batlle A. Aminolevulinic acid derivatives and liposome delivery as strategies for improving 5-aminolevulinic acid-mediated photodynamic therapy. Curr Med Chem. 2006;13:1157-1168.
20. Oo MK, Yang X, Du H, Wang H. 5-aminolevulinic acid-conjugated gold nanoparticles for photodynamic therapy of cancer. Nanomedicine (Lond). 2008;3:777-786.
21. Ding H, Sumer BD, Kessinger CW, et al. Nanoscopic micelle delivery improves the photophysical properties and efficacy of photodynamic therapy of protoporphyrin IX. J Control Release. 2011;151:271-277.
22. McCarthy JR, Perez JM, Brückner C, Weissleder R. Polymeric nanoparticle preparation that eradicates tumors. Nano Lett. 2005;5:2552-2556.
23. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 1994;263:1600-1603.
24. Nishiyama N, Okazaki S, Cabral H, et al. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res. 2003;63:8977-8983.
25. Seo DH, Jeong YI, Kim DG, Jang MJ, Jang MK, Nah JW. Methotrexate-incorporated polymeric nanoparticles of methoxy poly(ethylene glycol)-grafted chitosan. Colloids Surf B Biointerfaces. 2009;69:157-163.
26. Ganji F, Abdekhodaie MJ. Synthesis and characterization of a new thermosensitive chitosan-PEG diblock copolymer. Carbohydrate Polym. 2008;74:435-441.
27. Wang JJ, Zeng ZW, Xiao RZ, et al. Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomedicine. 2011;6:765-774.
28. Yoo HS, Lee JE, Chung H, Kwon IC, Jeong SY. Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery. J Control Release. 2005;103:235-243.
29. Wang XL, Wang HW, Guo MX, Xu SZ. Treatment of skin cancer and pre-cancer using topical ALA-PDT-a single hospital experience. Photodiagnosis Photodyn Ther. 2008;5:127-133.
30. Yang J, Xia Y, Liu X, Jiang S, Xiong L. Desferrioxamine shows different potentials for enhancing 5-aminolevulinic acid-based photodynamic therapy in several cutaneous cell lines. Lasers Med Sci. 2010;25: 251-257.
31. Tierney E, Barker A, Ahdout J, Hanke CW, Moy RL, Kouba DJ. Photodynamic therapy for the treatment of cutaneous neoplasia, inflammatory disorders, and photoaging. Dermatol Surg. 2009;35:725-746.
32. Kosaka S, Akilov OE, O'Riordan K, Hasan T. A mechanistic study of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis. J Invest Dermatol. 2007;127:1546-1549.
33. Yang SJ, Lin FH, Tsai KC, et al. Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells. Bioconjugate Chem. 2010;21:679-689.
34. Sharma S, Kulkarni J, Pawar AP. Permeation enhancers in the transmucosal delivery of macromolecules. Pharmazie. 2006;61:495-504.
35. Takeuchi H, Matsui Y, Yamamoto H, Kawashima Y. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Control Release. 2003;86:235-242.
36. Chung KD, Jeong YI, Chung CW, Kim do H, Kang DH. Anti-tumor activity of all-trans retinoic acid-incorporated glycol chitosan nanoparticles against HuCC-T1 human cholangiocarcinoma cells. Int J Pharm. 2012;422:454-461.
37. Filip A, Clichici S, Muresan A, et al. Effects of PDT with 5-aminolevulinic acid and chitosan on Walker carcinosarcoma. Exp Oncol. 2008;30(3):212-219.
38. Yang SJ, Lin FH, Tsai KC, et al. Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells. Bioconjug Chem. 2010;21:679-689.
39. Kim CH, Chung CW, Choi KH, et al. Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells. Int J Nanomedicine. 2011;6: 1357-1363.
40. Grimm S, Mvondo D, Grune T, Breusing N. The outcome of 5-ALA mediated photodynamic treatment in melanoma cells is influenced by vitamin C and heme oxygenase-1. Biofactors. 2011;37(1):17-24.
41. Moon YH, Park JH, Kim SA, Lee JB, Ahn SG, Yoon JH. Anticancer effect of photodynamic therapy with hexenyl ester of 5-aminolevulinic acid in oral squamous cell carcinoma. Head Neck. 2010;32(9): 1136-1142.